The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.

dc.contributor.author	Demir, Ferhat
dc.contributor.author	Aktay Ayaz, Nuray
dc.contributor.author	Çakan, Mustafa
dc.contributor.author	Otar Yener, Gülçin
dc.contributor.author	Özdel, Semanur
dc.contributor.author	Sözeri, Betül
dc.contributor.author	Sönmez, Hafize E
dc.contributor.author	Karadağ, Şerife G
dc.contributor.author	Bağlan, Esra
dc.contributor.author	Öztürk, Kübra
dc.date.accessioned	2021-12-10T10:23:33Z
dc.date.available	2021-12-10T10:23:33Z
dc.date.issued	2021
dc.identifier.citation	Sözeri B., Sönmez H. E. , Karadağ Ş. G. , Bağlan E., Öztürk K., Çakan M., Demir F., Otar Yener G., Özdel S., Aktay Ayaz N., "The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.", Clinical and experimental rheumatology, cilt.39, sa.5, ss.118-123, 2021
dc.identifier.issn	0392-856X
dc.identifier.other	vv_1032021
dc.identifier.other	av_3cea63ee-519f-4cef-9c2c-d74ff65aaf9a
dc.identifier.uri	http://hdl.handle.net/20.500.12627/169790
dc.language.iso	eng
dc.title	The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients.
dc.type	Makale
dc.relation.journal	Clinical and experimental rheumatology
dc.contributor.department	, ,
dc.identifier.volume	39
dc.identifier.issue	5
dc.identifier.startpage	118
dc.identifier.endpage	123
dc.contributor.firstauthorID	2756882

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.